Business Description
BioLight Life Sciences Ltd
ISIN : IL0010952237
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 39.87 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | N/A | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.95 | |||||
Beneish M-Score | 14.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 16.8 | |||||
3-Year EPS without NRI Growth Rate | 11 | |||||
3-Year FCF Growth Rate | 14.7 | |||||
3-Year Book Growth Rate | -8.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.84 | |||||
9-Day RSI | 23.05 | |||||
14-Day RSI | 29.16 | |||||
6-1 Month Momentum % | -16.02 | |||||
12-1 Month Momentum % | -30.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Days Sales Outstanding | 2258.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -3.57 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -12289.01 | |||||
Net Margin % | -32018.68 | |||||
FCF Margin % | -12221.98 | |||||
ROE % | -49.35 | |||||
ROA % | -40.36 | |||||
ROIC % | -21.78 | |||||
ROC (Joel Greenblatt) % | -36.03 | |||||
ROCE % | -13.39 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 225.58 | |||||
PB Ratio | 0.37 | |||||
Price-to-Tangible-Book | 0.37 | |||||
EV-to-EBIT | -0.4 | |||||
EV-to-EBITDA | -0.43 | |||||
EV-to-Revenue | 41.34 | |||||
EV-to-FCF | -0.34 | |||||
Price-to-Net-Current-Asset-Value | 1.38 | |||||
Earnings Yield (Greenblatt) % | -250 | |||||
FCF Yield % | -56.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BioLight Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 0.091 | ||
EPS (TTM) (₪) | -6.33 | ||
Beta | 0 | ||
Volatility % | 26.57 | ||
14-Day RSI | 29.16 | ||
14-Day ATR (₪) | 0.153894 | ||
20-Day SMA (₪) | 4.7083 | ||
12-1 Month Momentum % | -30.63 | ||
52-Week Range (₪) | 4.174 - 7.589 | ||
Shares Outstanding (Mil) | 4.58 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioLight Life Sciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioLight Life Sciences Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
BioLight Life Sciences Ltd Frequently Asked Questions
What is BioLight Life Sciences Ltd(XTAE:BOLT)'s stock price today?
When is next earnings date of BioLight Life Sciences Ltd(XTAE:BOLT)?
Does BioLight Life Sciences Ltd(XTAE:BOLT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |